- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Court allows Aurobindo Pharma head Sarath P Reddy to turn ED's approver in alleged excise policy case
![Court allows Aurobindo Pharma head Sarath P Reddy to turn EDs approver in alleged excise policy case Court allows Aurobindo Pharma head Sarath P Reddy to turn EDs approver in alleged excise policy case](https://medicaldialogues.in/h-upload/2023/01/10/750x450_197263-aurobindo-pharma-1.webp)
New Delhi: The Rouse Avenue Court on Thursday allowed the Hyderabad-based businessman P Sarath Reddy to turn approver for ED in an alleged excise policy case.
Sarath P Reddy was recently granted regular bail by Delhi High Court on medical grounds. Reddy is the head of a Hederabad-based Aurobindo Pharma company and is engaged in liquor business, said the ED in court earlier.
Read also: Aurobindo Pharma Director gets bail in Delhi Excise Policy Case
While arguing against Sarath Reddy, ED earlier submitted that it is amply evident that, he had actively planned and conspired with various business owners and politicians and indulged in unfair market practices to gain undue advantage in the Delhi Excise Policy, 2021-22. Applicant led a nexus controlling a considerable market share through cartelization in clear contravention of objectives of Delhi Excise Policy.
Earlier, Delhi-based businessman Dinesh Arora turned approbation in CBI case. While moving an application Arora said, ” I am ready to make true disclosure voluntarily about the case and want to be an approver in the case”
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751